Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.

× No keyword cloud information.

12 in total

1. Beta adrenergic dilator component of the sympathetic vascular response in skeletal muscle. Influence on the micro-circulation and on transcapillary exchange.

Authors: J Lundvall; J Järhult
Journal: Acta Physiol Scand Date: 1976-02

2. Responses of the cardiovascular system of the rat to noradrenaline infusions and their modification by adrenoceptor blocking agents.

Authors: F J Imms; R L Neame; D A Powis
Journal: Br J Pharmacol Date: 1977-05 Impact factor: 8.739

3. The effect of changes in local temperature on the blood flows of the normal hand, primary Raynaud's disease and primary acrocyanosis.

Authors: J H PEACOCK
Journal: Clin Sci Date: 1960-11 Impact factor: 6.124

4. Raynaud's phenomenon as side effect of beta-blockers in hypertension.

Authors: A J Marshall; C J Roberts; D W Barritt
Journal: Br Med J Date: 1976-06-19

5. Raynaud's disease: reduced hand blood flows with normal blood viscosity.

Authors: M A McGrath; R Peek; R Penny
Journal: Aust N Z J Med Date: 1978-04

6. Haemodynamic changes in long-term therapy of essential hypertension: a comparative study of diuretics, alpha-methyldopa and clonidine.

Authors: P Lung-Johansen
Journal: Clin Sci Mol Med Suppl Date: 1973-08

7. The mechanisms of Raynaud's phenomenon: Part 1.

Authors: M A McGrath; R Penny
Journal: Med J Aust Date: 1974-08-31 Impact factor: 7.738

8. Effects of propranolol on peripheral vessels in man.

Authors: I Brick; W E Glover; K J Hutchison; I C Roddie
Journal: Am J Cardiol Date: 1966-09 Impact factor: 2.778

Review 9. Pharmacological effects of labetalol in man.

Authors: D A Richards
Journal: Br J Clin Pharmacol Date: 1976-08 Impact factor: 4.335

10. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.

Authors: J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal: Br J Pharmacol Date: 1972-08 Impact factor: 8.739

6 in total

Review 1. Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis.

Authors: Charles Khouri; Thomas Jouve; Sophie Blaise; Patrick Carpentier; Jean-Luc Cracowski; Matthieu Roustit
Journal: Br J Clin Pharmacol Date: 2016-05-31 Impact factor: 4.335

Review 2. Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors: Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal: Br J Clin Pharmacol Date: 2016-04-07 Impact factor: 4.335

3. Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease.

Authors: E van der Veur; B S ten Berge; A A Wouda; H Wesseling
Journal: Eur J Clin Pharmacol Date: 1985 Impact factor: 2.953

Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.